INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

76,508 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M$73K
52.4K sh
May 5, 2026May 6, 2026
Page 1005 of 1913
← PrevNext →
traded May 5, 2026
+1d
SEC Form 4

Evidence

2
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
355.0K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

2
DA
D'Amico AndrewDirector
VICRVICOR CORP
Grant or award
A—
4,100 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

2
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Disposition to issuer
D—
11.2K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
53.3K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$448K
20.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

2
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
355.0K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

2
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
11.2K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
53.3K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Grant or award
A$18K
99 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

2
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Derivative conversion
C—
11.2K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
SM
Stetz MattiasChief Operating Officer
RSIRush Street Interactive, Inc.
Disposition to issuer
D—
11.2K sh
May 6, 2026May 6, 2026
traded May 6, 2026
+0dSEC Form 4

Evidence

2
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Grant or award
A—
10.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
1,065 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

1
HF
Howe James F.President, Motion
GPCGENUINE PARTS CO
Open-market sale · 10b5-1 plan
SELL$43K
415 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

1
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$63K
140 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Option exercise · 10b5-1 plan
M—
5,486 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M$148K
600 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

0
FW
Fordenwalt Matthew W.SVP Lifecycle Services
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
600 sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

0
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
23.1K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,250 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
8,500 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Option exercise · 10b5-1 plan
M—
1,988 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
300.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
8,500 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Tax withholding · 10b5-1 plan
F$3,288
896 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
75.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
22.5K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
75.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
300.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Option exercise · 10b5-1 plan
M$3,292
5,486 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
23.1K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Option exercise · 10b5-1 plan
M$954
1,988 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
45.0K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,250 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Tax withholding · 10b5-1 plan
F$954
260 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,250 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
22.5K sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence

0
HK
Holleran KevinDirector, President and CEO
HAYWHayward Holdings, Inc.
Option exercise · 10b5-1 plan
M—
52.4K sh
May 5, 2026May 6, 2026
traded May 5, 2026
+1dSEC Form 4

Evidence

0
CR
Cline Christopher R.CHIEF FINANCIAL OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,250 sh
May 4, 2026May 6, 2026
traded May 4, 2026
+2dSEC Form 4

Evidence